Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-17

Clinical Trial Update: Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial investigating propranolol hydrochloride in patients with prostate cancer undergoing surgery was terminated, and results were posted in February 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propranolol Hydrochloride (propranolol hydrochloride)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Prostate Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2025-02-17